In the subgroup analyses that were adjusted according to the clinicopathological characteristics including fibrosis severity, the serum ITIH4 expression in the HCC with NAFLD group was significantly higher than that in the NASH group (Table 3). The gene discussed is ITIH4; the disease is metabolic dysfunction-associated steatotic liver disease.